ArticleChinese medical journal2026

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia.

Hexian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.